169
Participants
Start Date
December 1, 2022
Primary Completion Date
October 23, 2024
Study Completion Date
November 11, 2024
Placebo
Matching placebo capsule(s) administered every day (QD) orally. Titration may proceed at a rate of 1 matching placebo capsule per day every 7 days as required for optimal efficacy and tolerability up to a maximum number of 3 matching placebo capsules per day.
Suvecaltamide
Suvecaltamide capsule administered every day (QD) orally. Titration may proceed at a rate of 10 mg suvecaltamide per day every 7 days as required for optimal efficacy and tolerability up to a maximum dose of 30 mg suvecaltamide per day.
Columbia University Irving Medical Center, New York
South Shore Neurologic Associates PC, Patchogue
Albany Medical College, Albany
Dent Neurologic Institute, Amherst
Hospital Universitario de La Princesa, Madrid
Hospital Ramón y Cajal, Madrid
NeuroTrials Research Inc., Atlanta
Clinical Neuroscience Solutions, Inc., Jacksonville
Neurology of Central Florida Research Center LLC, Altamonte Springs
Parkinson's Disease and Movement Disorder Center of Boca Raton, Boca Raton
USF Parkinson's Disease and Movement Disorders Center, Tampa
Vanderbilt University Medical Center, Nashville
University of Kentucky, College of Medicine, Department of Neurology, Lexington
Hospital Universitario Virgen Macarena, Seville
University of Cincinnati Gardner Neuroscience Institute (UCGNI), Cincinnati
Hospital Universitario Cruces, Barakaldo
Northwestern Medical Group, Department of Neurology, Chicago
Zentrum f. klinische Forschung Dr. I. Schöll, Bad Homburg
Velocity Clinical Research Germany GmbH, Location Wiesbaden, Wiesbaden
Deutsche Klinik fur Diagnostik Helios Klinik Wiesbaden, Hessen
University of Kansas Medical Center, Kansas City
Central Texas Neurology Consultants, Round Rock
University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora
Curiositas-ad-sanum Beratungs-und Studien GmbH, Haag in Oberbayern
Movement Disorders Center of Arizona, Scottsdale
The Nene and Jamie Koch Comprehensive Movement Disorders Center, Albuquerque
Keck School of Medicine of University of Southern California (USC), Los Angeles
Hawaii Pacific Health, Honolulu
EverGreenHealth Neuroscience Institute, Kirkland
Pharmakologisches Studienzentrum Chemnitz GmbH, Chemnitz
Neurologia Slaska Centrum Medyczne, Katowice
Centrum Medyczne Plejady, Krakow
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M.i M. Nastaj Spólka Partnerska, Lublin
Maxxmed Centrum Zdrowia i Urody w Lublinie, Lublin
Gabinety Lekarskie Rivermed Sp. z o.o., Poznan
ETG Neuroscience Sp. z o.o., Warsaw
Hospital de la Santa Creu i Sant Pau, Barcelona
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY